COVID-19 and hyponatremia

Abstract

Abstract: The worldwide spread of coronavirus disease 2019 (COVID-19) has caused a heavy burden on the public health of all countries. As the specific antiviral treatment is not available, it is necessary to monitor various clinical indicators, and minimize the risk factors related to poor outcomes in the management of COVID-19. COVID-19 is often presented with hyponatremia which is frequently associated with prolonged hospitalization, increased rate of intensive care unit transfer, higher risk of severe pneumonia and mortality. Hyponatremia is an important index for early identification of patients with poor prognosis. COVID-19 related hyponatremia is mainly caused by inappropriate antidiuretic hormone secretion syndrome and hypovolemia. If hyponatremia can be diagnosed and corrected in time, the poor clinical outcomes related to hyponatremia can be prevented.

Key words: coronavirus disease 2019, hyponatremia, syndrome of inappropriate antidiuresis hormone

CLC Number:

R589.4

LIANG Si-yu, CHEN Shi, PAN Hui, JIAJUE Rui-zhi, ZHU Hui-juan. COVID-19 and hyponatremia[J]. Basic & Clinical Medicine, 2021, 41(12): 1843-1847.

References

[1]Akirov A, Diker-Cohen T, Steinmetz T, et al. Sodium levels on admission are associated with mortality risk in hospitalized patients[J]. Eur J Intern Med, 2017, 46:25-29.
[2]Al Mawed S, Pankratz VS, Chong K, et al. Low serum sodium levels at hospital admission: outcomes among 2.3 million hospitalized patients[J]. PLoS One, 2018, 13:e0194379.doi:10.1371/journal.pone.0194379.
[3]Hao J, Li Y, Zhang X, et al. The prevalence and mortality of hyponatremia is seriously underestimated in Chinese general medical patients: an observational retrospective study[J]. BMC Nephrol, 2017, 18:328.doi:10.1186/s12882-017-0744-x.
[4]Sterns RH. Disorders of plasma sodium--causes, consequences, and correction[J]. N Engl J Med, 2015, 372:55-65.
[5]Waikar SS, Mount DB, Curhan GC. Mortality after hospitalization with mild, moderate, and severe hyponatremia[J]. Am J Med, 2009, 122:857-865.
[6]Królicka AL, Kruczkowska A, Krajewska M, et al. Hyponatremia in infectious diseases-a literature review[J]. Int J Environ Res Public Health, 2020, 17:5320.doi:10.3390/ijerph17155320.
[7]Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong[J]. Ann Intern Med, 2003, 139:715-723.
[8]Wu Y, Hou B, Liu J, et al. Risk factors associated with long-term hospitalization in patients with COVID-19: a single-centered, retrospective study[J]. Front Med (Lausanne), 2020, 7:315.doi:10.3389/fmed.2020.00315.
[9]Duan J, Wang X, Chi J, et al. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing[J]. J Med Virol, 2020, 92:2616-2622.
[10]Khan AA, Ata F, Munir W, et al. Fluid replacement versus fluid restriction in COVID-19 associated hyponatremia[J]. Cureus, 2020, 12:e9059.doi:10.7759/cureus.9059.
[11]Tee LY, Yap B, Sidhu GK, et al. Atypical presentation of COVID-19 in an older adult: lethargy and vomiting from severe hypovolemic hyponatremia[J]. Geriatr Gerontol Int, 2020, 20:839-840.
[12]Habib MB, Sardar S, Sajid J. Acute symptomatic hyponatremia in setting of SIADH as an isolated presentation of COVID-19[J]. IDCases, 2020, 21:e00859.doi:10.1016/j.idcr.2020.e00859.
[13]Tsai CC, Wang YC, Chiang TT, et al. Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan[J]. J Formos Med Assoc, 2021, 120:713-719.
[14]Berni A, Malandrino D, Parenti G, et al. Hyponatremia, IL-6, and SARS-CoV-2 (COVID-19) infection: may all fit together?[J]. J Endocrinol Invest, 2020, 43:1137-1139.
[15]Ghahramani S, Tabrizi R, Lankarani KB, et al. Labora-tory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis[J]. Eur J Med Res, 2020, 25:30.doi:10.1186/s40001-020-00432-3.
[16]Levy TJ, Richardson S, Coppa K, et al. Development and validation of a survival calculator for hospitalized patients with COVID-19[J]. medRxiv, 2020.doi:10.1101/2020.04.22.20075416.
[17]Cuesta M, Thompson C. The syndrome of inappropriate antidiuresis (SIAD)[J]. Best Pract Res Clin Endocrinol Metab, 2016, 30:175-187.
[18]Esposito P, Piotti G, Bianzina S, et al. The syndrome of inappropriate antidiuresis: pathophysiology, clinical management and new therapeutic options[J]. Nephron Clin Pract, 2011, 119:c62-73.doi:10.1159/000324653.
[19]Gemcioglu E, Karabuga B, Ercan A, et al. A case of inappropriate antidiuretic hormone secretion syndrome associated with COVID-19 pneumonia[J]. Acta Endocrinol (Buchar), 2020, 16:110-111.
[20]Sheikh MM, Ahmad E, Jeelani HM, et al. COVID-19 pneumonia: an emerging cause of syndrome of inappro-priate antidiuretic hormone[J]. Cureus, 2020, 12:e8841.doi:10.7759/cureus.8841.
[21]Yousaf Z, Al-Shokri SD, Al-soub H, et al. COVID-19-associated SIADH: a clue in the times of pandemic![J]. Am J Physiol Endocrinol Metab, 2020, 318:E882-E885.
[22]Mastorakos G, Weber JS, Magiakou MA, et al. Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion[J]. J Clin Endocrinol Metab, 1994, 79:934-939.
[23]Park SJ, Shin JI. Inflammation and hyponatremia: an underrecognized condition?[J]. Korean J Pediatr, 2013, 56:519-522.
[24]Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosup-pression[J]. Lancet, 2020, 395:1033-1034.
[25]De La Flor Merino JC, Mola Reyes L, Linares Gravalos T, et al. An unusual case of severe acute hyponatremia in patient with COVID-19 infection[J]. Nefrologia, 2020, 40:356-358.